What is medication-assisted treatment (MAT)?
Medication-assisted treatment is the use of FDA-approved medications (such as methadone, buprenorphine, or naltrexone) combined with behavioral therapy and counseling to treat opioid and alcohol use disorders.
Medication-assisted treatment combines prescription medications with behavioral counseling and psychosocial support to address substance use disorders. The approach recognizes that medication alone does not solve addiction, nor does counseling without pharmacological support work optimally for many individuals. The two elements work together to reduce cravings, ease withdrawal symptoms, and address the underlying drivers of substance use.
The most common medications used in MAT are methadone, buprenorphine, and naltrexone. Methadone is a synthetic opioid agonist that prevents withdrawal and reduces cravings in people with opioid dependence. Buprenorphine is a partial opioid agonist that carries lower overdose risk than methadone. Naltrexone is an opioid antagonist that blocks the rewarding effects of opioids and is also used for alcohol use disorder. Each medication requires medical oversight, and selection depends on the individual's diagnosis, medical history, and treatment goals.
The counseling component in MAT typically includes individual therapy, group sessions, and sometimes family involvement. Counselors help patients develop coping strategies, address co-occurring mental health conditions, rebuild relationships, and work toward sustained recovery. In Columbia, substance-abuse counseling providers often integrate MAT within their treatment plans when appropriate, working alongside physicians or specialized clinics that prescribe the medications.